TickerFactsScreenerDevelopers

LISATA THERAPEUTICS, INC. (LSTA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$8.48M2011: -$20.93M2012: -$13.85M2013: -$27.10M2014: -$46.90M2015: -$39.26M2016: -$23.67M2017: -$20.88M2018: -$19.99M2019: -$18.88M2020: -$8.82M2021: -$22.25M2022: -$21.17M2023: -$20.03M2024: -$19.36M2025: -$15.95M-$15.95M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$15.95M+17.6%
2024-$19.36M+3.4%
2023-$20.03M+5.4%
2022-$21.17M+4.8%
2021-$22.25M-152.1%
2020-$8.82M+53.3%
2019-$18.88M+5.5%
2018-$19.99M+4.3%
2017-$20.88M+11.8%
2016-$23.67M+39.7%
2015-$39.26M+16.3%
2014-$46.90M-73.0%
2013-$27.10M-95.6%
2012-$13.85M+33.8%
2011-$20.93M-146.9%
2010-$8.48M—